Replay available

Bioventus Inc. (BVS) Q4 2025 Earnings Call

Bioventus Inc. (NASDAQ: BVS) Q4 2025 earnings conference call, held 2026-03-05. Replay captured from the company's public earnings webcast.

Thu, March 5, 2026 at 8:30 AMendedReplay
Bioventus Inc. (BVS) Q4 2025 Earnings Call

Hosted by

Featured presenters

Dave Crawford

Director of Investor Relations

Rob Claypool

President and CEO

Mark Singleton

Senior Vice President and CFO

Chase Knickerbocker

Analyst, Craig Hallam Capital Group

Mike Potusky

Analyst, Barrington Research

Caitlin Roberts

Analyst, Canaccord Genuity

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Bioventus Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.759 Good day and welcome to the BioVentus fourth quarter 2025 earnings 00:00:04.759 -- 00:00:08.426 conference call. All participants will be in a listen-only mode. 00:00:08.426 -- 00:00:12.012 Should you need assistance, please signal conference specialists by pressing the star 00:00:12.012 -- 00:00:16.600 key followed by zero. After today's presentation, there will be an opportunity to ask 00:00:16.600 -- 00:00:22.070 questions. To ask a question, you may press star then one on your touchtone phone. 00:00:22.070 -- 00:00:25.529 And to withdraw your question, please press star then two. 00:00:25.529 -- 00:00:29.273 Please note this event is being recorded. I would now like to turn the conference over 00:00:29.273 -- 00:00:32.978 to Mr. Dave Crawford. Please go ahead. 00:00:32.978 -- 00:00:34.499 Thanks, Chuck, and good morning, everyone. 00:00:34.499 -- 00:00:39.165 Thanks for joining us. It's my pleasure to welcome you to the BioVentus 2025 Fourth Quarter 00:00:39.165 -- 00:00:44.110 Earnings Conference Call. With me this morning are Rob Claypool, President and CEO, and 00:00:44.110 -- 00:00:47.134 Mark Singleton, Senior Vice President and CFO. 00:00:47.134 -- 00:00:50.998 Rob will begin his remarks with an update on our business, review our performance against 00:00:50.998 -- 00:00:55.533 our 2025 priorities, and lay out our 2026 objectives. 00:00:55.533 -- 00:01:00.659 Then Mark will review the fourth quarter results and discuss our 2026 financial guidance. 00:01:00.659 -- 00:01:05.665 We'll finish the call with Q&A. A presentation for today's call is available in the Investors 00:01:05.665 -- 00:01:08.966 section of our website, bioventus.com. 00:01:09.069 -- 00:01:12.994 Before we begin, I would like to remind everyone that our r...